Sunder Biomedical Tech. Co., Ltd.(TW:4115)
NT$6.970.00 (0.00%)
TW:4115
Sunder Biomedical Tech. Co., Ltd. financials statements
NT$6.97
At close:0.00 (0.00%)
Sunder Biomedical Tech. Co., Ltd. (4115) Income Statement
Sunder Biomedical Tech. Co., Ltd. Income Statement
Last quarter (Q2 2026), Sunder Biomedical Tech. Co., Ltd.'s total revenue was NT$367.66M, a decrease of 5.82% from the same quarter last year. In Q2, Sunder Biomedical Tech. Co., Ltd.'s net income was NT$2.39M. See Sunder Biomedical Tech. Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 753.45M | NT$ 766.83M | NT$ 770.19M | NT$ 1.05B | NT$ 1.14B | |
| NT$ 102.48M | NT$ 142.11M | NT$ 77.91M | NT$ 140.52M | NT$ 200.78M | |
| NT$ 120.81M | NT$ 118.02M | NT$ 115.33M | NT$ 124.99M | NT$ 119.87M | |
| Depreciation and Amortization | NT$ 86.76M | NT$ 84.27M | NT$ 104.62M | NT$ 104.50M | NT$ 96.43M |
| NT$ 68.43M | NT$ 125.61M | NT$ 76.61M | NT$ 127.49M | NT$ 193.39M | |
| NT$ -18.33M | NT$ 24.09M | NT$ -37.41M | NT$ 15.80M | NT$ 80.91M | |
| NT$ -7.41M | NT$ 6.33M | NT$ -3.11M | NT$ -3.57M | NT$ 6.87M | |
| NT$ -25.74M | NT$ 30.41M | NT$ -40.52M | NT$ 12.23M | NT$ 87.77M | |
| NT$ -16.26M | NT$ 29.10M | NT$ -33.16M | NT$ 13.32M | NT$ 71.06M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -0.27 | NT$ 0.49 | NT$ -0.55 | NT$ 0.22 | NT$ 1.18 |
| Diluted EPS | NT$ -0.27 | NT$ 0.48 | NT$ -0.55 | NT$ 0.22 | NT$ 1.18 |
| Weighted Average Shares Outstanding | 60.22M | 60.00M | 60.00M | 60.00M | 60.00M |
| Weighted Average Shares Outstanding (Diluted) | 60.22M | 60.05M | 60.00M | 60.06M | 60.17M |
Currency in TWD
